Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

SLC25A11 Peptide

For modified antibodies, we provide modified peptides(0.5mg) and non-modified peptides (0.5 mg).

Product Specifications

Reactivity

Antibody available as DF4173

Source

Synthetic

Applications

Blocking/Control

Concentration

10 mg/mL

Function

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (immunoblot) and immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or immunostaining performed with the neutralized antibody.

Precautions

This product is for research use only. Not for use in diagnostic or therapeutic procedures.

Related Products

DF4173

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

BSDC1 Antibody
KC-42619-01 50 μL

BSDC1 Antibody

Sign In for Pricing
View Details
BSDC1 Antibody
KC-42619-02 100 µL

BSDC1 Antibody

Sign In for Pricing
View Details
BSDC1 Antibody
KC-42619-03 1 mL

BSDC1 Antibody

Sign In for Pricing
View Details
GATA-3 (Breast and Urothelial Marker) (GATA3/2441), CF568 conjugate, 0.1mg/mL
BNC682441-100 1x 100 µL

GATA-3 (Breast and Urothelial Marker) (GATA3/2441), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
myosin light chain 1 (MYL1) Mouse Monoclonal Antibody [Clone ID: OTI1D9]
CF810681 100 µg

myosin light chain 1 (MYL1) Mouse Monoclonal Antibody [Clone ID: OTI1D9]

Sign In for Pricing
View Details
Tissue FFPE Sections, Colon: right
CS808969 5x 5 µm

Tissue FFPE Sections, Colon: right

Sign In for Pricing
View Details